These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 22308110)
1. Histone deacetylase inhibition in colorectal cancer cells reveals competing roles for members of the oncogenic miR-17-92 cluster. Humphreys KJ; Cobiac L; Le Leu RK; Van der Hoek MB; Michael MZ Mol Carcinog; 2013 Jun; 52(6):459-74. PubMed ID: 22308110 [TBL] [Abstract][Full Text] [Related]
2. TSA suppresses miR-106b-93-25 cluster expression through downregulation of MYC and inhibits proliferation and induces apoptosis in human EMC. Zhao ZN; Bai JX; Zhou Q; Yan B; Qin WW; Jia LT; Meng YL; Jin BQ; Yao LB; Wang T; Yang AG PLoS One; 2012; 7(9):e45133. PubMed ID: 23028803 [TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor SAHA epigenetically regulates miR-17-92 cluster and MCM7 to upregulate MICA expression in hepatoma. Yang H; Lan P; Hou Z; Guan Y; Zhang J; Xu W; Tian Z; Zhang C Br J Cancer; 2015 Jan; 112(1):112-21. PubMed ID: 25393367 [TBL] [Abstract][Full Text] [Related]
4. Butyrate inhibits pro-proliferative miR-92a by diminishing c-Myc-induced miR-17-92a cluster transcription in human colon cancer cells. Hu S; Liu L; Chang EB; Wang JY; Raufman JP Mol Cancer; 2015 Oct; 14():180. PubMed ID: 26463716 [TBL] [Abstract][Full Text] [Related]
5. Histone deacetylases inhibitor trichostatin A increases the expression of Dleu2/miR-15a/16-1 via HDAC3 in non-small cell lung cancer. Chen CQ; Chen CS; Chen JJ; Zhou LP; Xu HL; Jin WW; Wu JB; Gao SM Mol Cell Biochem; 2013 Nov; 383(1-2):137-48. PubMed ID: 23867991 [TBL] [Abstract][Full Text] [Related]
6. Histone deacetylase inhibitors alter the expression of molecular markers in breast cancer cells via microRNAs. Shi Y; Jia Y; Zhao W; Zhou L; Xie X; Tong Z Int J Mol Med; 2018 Jul; 42(1):435-442. PubMed ID: 29620153 [TBL] [Abstract][Full Text] [Related]
7. Sodium Butyrate Upregulates miR-203 Expression to Exert Anti-Proliferation Effect on Colorectal Cancer Cells. Han R; Sun Q; Wu J; Zheng P; Zhao G Cell Physiol Biochem; 2016; 39(5):1919-1929. PubMed ID: 27771718 [TBL] [Abstract][Full Text] [Related]
8. Nuclear factor-kappaB p65 small interfering RNA or proteasome inhibitor bortezomib sensitizes head and neck squamous cell carcinomas to classic histone deacetylase inhibitors and novel histone deacetylase inhibitor PXD101. Duan J; Friedman J; Nottingham L; Chen Z; Ara G; Van Waes C Mol Cancer Ther; 2007 Jan; 6(1):37-50. PubMed ID: 17237265 [TBL] [Abstract][Full Text] [Related]
9. miR-18a inhibits CDC42 and plays a tumour suppressor role in colorectal cancer cells. Humphreys KJ; McKinnon RA; Michael MZ PLoS One; 2014; 9(11):e112288. PubMed ID: 25379703 [TBL] [Abstract][Full Text] [Related]
10. MicroRNA-31 is a transcriptional target of histone deacetylase inhibitors and a regulator of cellular senescence. Cho JH; Dimri M; Dimri GP J Biol Chem; 2015 Apr; 290(16):10555-67. PubMed ID: 25737447 [TBL] [Abstract][Full Text] [Related]
11. The pan-deacetylase inhibitor panobinostat suppresses the expression of oncogenic miRNAs in hepatocellular carcinoma cell lines. Henrici A; Montalbano R; Neureiter D; Krause M; Stiewe T; Slater EP; Quint K; Ocker M; Di Fazio P Mol Carcinog; 2015 Aug; 54(8):585-97. PubMed ID: 24375802 [TBL] [Abstract][Full Text] [Related]
12. miR-30d, miR-181a and miR-199a-5p cooperatively suppress the endoplasmic reticulum chaperone and signaling regulator GRP78 in cancer. Su SF; Chang YW; Andreu-Vieyra C; Fang JY; Yang Z; Han B; Lee AS; Liang G Oncogene; 2013 Sep; 32(39):4694-701. PubMed ID: 23085757 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-16 mediates the regulation of a senescence-apoptosis switch in cutaneous T-cell and other non-Hodgkin lymphomas. Kitadate A; Ikeda S; Teshima K; Ito M; Toyota I; Hasunuma N; Takahashi N; Miyagaki T; Sugaya M; Tagawa H Oncogene; 2016 Jul; 35(28):3692-704. PubMed ID: 26640145 [TBL] [Abstract][Full Text] [Related]
14. HTP Nutraceutical Screening for Histone Deacetylase Inhibitors and Effects of HDACis on Tumor-suppressing miRNAs by Trichostatin A and Grapeseed (Vitis vinifera) in HeLa cells. Mazzio EA; Soliman KF Cancer Genomics Proteomics; 2017 Jan; 14(1):17-33. PubMed ID: 28031235 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21 promotes phosphatase gene and protein kinase B/phosphatidylinositol 3-kinase expression in colorectal cancer. Sheng WZ; Chen YS; Tu CT; He J; Zhang B; Gao WD World J Gastroenterol; 2016 Jun; 22(24):5532-9. PubMed ID: 27350731 [TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors induce attenuation of Wnt signaling and TCF7L2 depletion in colorectal carcinoma cells. Götze S; Coersmeyer M; Müller O; Sievers S Int J Oncol; 2014 Oct; 45(4):1715-23. PubMed ID: 25050608 [TBL] [Abstract][Full Text] [Related]
18. De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures. Ernst A; Campos B; Meier J; Devens F; Liesenberg F; Wolter M; Reifenberger G; Herold-Mende C; Lichter P; Radlwimmer B Oncogene; 2010 Jun; 29(23):3411-22. PubMed ID: 20305691 [TBL] [Abstract][Full Text] [Related]
19. Suberoylanilide hydroxamic acid induces thioredoxin1-mediated apoptosis in lung cancer cells via up-regulation of miR-129-5p. You BR; Park WH Mol Carcinog; 2017 Dec; 56(12):2566-2577. PubMed ID: 28667779 [TBL] [Abstract][Full Text] [Related]
20. E2F1-regulated microRNAs impair TGFbeta-dependent cell-cycle arrest and apoptosis in gastric cancer. Petrocca F; Visone R; Onelli MR; Shah MH; Nicoloso MS; de Martino I; Iliopoulos D; Pilozzi E; Liu CG; Negrini M; Cavazzini L; Volinia S; Alder H; Ruco LP; Baldassarre G; Croce CM; Vecchione A Cancer Cell; 2008 Mar; 13(3):272-86. PubMed ID: 18328430 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]